Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism

Publisher： Karger

E-ISSN： 1421-9670|43|3|213-220

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.43, Iss.3, 2016-04, pp. : 213-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients on Sevelamer Hydrochloride: Which Dialysate Calcium Concentration to Use?

By  

Blood Purification, Vol. 27, Iss. 2, 2009-01 ,pp. : 182-186

Karger

Access to resources Recommend Favorite

Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

By  

Blood Purification, Vol. 16, Iss. 1, 1998-02 ,pp. : 22-29

Karger

Access to resources Recommend Favorite

Parathyroidectomy Reduces Intradialytic Hypotension in Hemodialysis Patients with Secondary Hyperparathyroidism

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 4-5, 2013-09 ,pp. : 323-331

Karger

Access to resources Recommend Favorite

Clinical Effect of Intravenous Calcitriol Administration on Secondary Hyperparathyroidism

By  

Nephron, Vol. 90, Iss. 4, 2002-04 ,pp. : 413-423

Karger

Access to resources Recommend Favorite

Effectiveness of Intravenous and Subcutaneous Calcitriol inthe Treatment of Secondary Hyperparathyroidism

By  

Nephron, Vol. 80, Iss. 1, 1998-09 ,pp. : 119-120

Karger

Access to resources Recommend Favorite